Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 5.2B | 5.0B | 5.2B | 4.8B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.8B | 1.7B | 1.7B | 1.7B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.0B | 1.9B | 2.0B | 1.7B |
Tax provision | 450.3M | 427.2M | 476.4M | 379.5M |
Net income | 1.5B | 1.5B | 1.6B | 1.4B |
Basic EPS | 2.2 | 2.1 | 2.2 | — |
Diluted EPS | 2.2 | 2.0 | 2.2 | — |
Basic average shares | 673.9M | 678.4M | 681.0M | — |
Diluted average shares | 677.7M | 681.5M | 684.8M | — |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.5B | 1.5B | 1.6B | 1.4B |
Minority interests | -1.4M | -6.5M | -5.8M | -5.8M |
Preferred stock dividends | — | — | — | — |